Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

During the Trading Day
13.87 -0.11 / -0.79%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
13.87 0.00 / 0.00%
 
Volume: 4.6K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$768.5M

Company Description

Momenta Pharmaceuticals, Inc. is a biotechnology company, engages in the structural analysis of complex mixture drugs. The company applies its technology to the development of generic versions of complex drug products, as well as to the discovery and development of complex novel drugs. It is also specialized in the structural characterization, process engineering and biologic systems analysis of complex molecules, such as polysaccharides, polypeptides and biologics, including proteins and antibodies. Momenta Pharmaceuticals was founded by Ram Sasisekharan and Ganesh Venkatraman in May 2001 and is headquartered in Cambridge, MA.

Contact Information

Momenta Pharmaceuticals, Inc.
675 West Kendall Street
Cambridge Massachusetts 02142
P:(617) 491-9700
Investor Relations:
(617) 395-5189

Employees

Shareholders

Mutual fund holders43.80%
Other institutional43.40%
Individual stakeholders26.76%

Top Executives

Craig A. WheelerPresident, Chief Executive Officer & Director
Richard P. SheaChief Financial Officer, Director & Senior VP
Ganesh Kaundinya VenkataramanChief Scientific Officer & Senior VP-Research
Ganesh V. KaundinyaChief Scientific Officer & Senior VP-Research
James M. RoachChief Medical Officer & Senior VP-Development

To view my watchlist

Not a member yet?

Sign up now for a free account